FDA awards $2.25M grant to study immunosuppresive drug in high-risk patients

(University of Cincinnati Academic Health Center) University of Cincinnati Research Professor Rita Alloway, PharmD, has been awarded a $2.25 million grant from the U.S. Food and Drug Administration to study the safety and efficacy of the generic immunosuppressive drug tacrolimus in transplant patients. As a "cornerstone drug" in post-transplant immunosuppression, tacrolimus is used to lower the risk of organ rejection -- these studies are aimed to address public concerns regarding the use of new generic formulations in high-risk transplant recipients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news